Lianhuan Pharmaceutical announces that in 2025, operating revenue will be 2.71B yuan, a year-on-year increase of 25.52%. Net profit will be a loss of 98.3324 million yuan, compared to a net profit of 84.16 million yuan in the same period last year. It is proposed that, based on the total share capital on the equity registration date for profit distribution in 2025, a cash dividend of 0.70 yuan (including tax) will be distributed for every 10 shares to all shareholders, totaling 19.9819 million yuan (including tax).

K-LinePoet

2026-04-22 04:05:17

Lianhuan Pharmaceutical announces that the operating revenue in 2025 will be 2.71B yuan, a year-on-year increase of 25.52%. Net profit is a loss of 98.3324 million yuan, compared to a net profit of 84.16 million yuan in the same period last year. It is proposed to distribute cash dividends of 0.70 yuan (including tax) for every 10 shares based on the total share capital on the profit distribution record date for 2025, totaling 19.9819 million yuan (including tax).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
313.1K Popularity
#
Gate13thAnniversaryLive
903.22K Popularity
#
BitcoinBouncesBack
181.16K Popularity
#
USIranTalksProgress
249.85K Popularity
#
ArbitrumFreezesKelpDAOHackerETH
37.51K Popularity

Sitemap

Lianhuan Pharmaceutical: Net profit loss of 98.3324 million yuan in 2025

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

BitcoinBouncesBack

USIranTalksProgress

ArbitrumFreezesKelpDAOHackerETH

Pin